Mirae Asset Global Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-901,835	Closed	-$660K	–	2632
2022 Q3	$660K	Sell	901,835 -330,621	-27%	-$375K	﹤0.01%	1718
2022 Q2	$1.41M	Sell	1,232,456 -12,785	-1%	-$16.3K	﹤0.01%	1252
2022 Q1	$2.55M	Sell	1,245,241 -123,198	-9%	-$293K	0.01%	1086
2021 Q4	$3.94M	Buy	1,368,439 +14,510	+1%	+$53.7K	0.01%	947
2021 Q3	$5.74M	Sell	1,353,929 -284,471	-17%	-$1.27M	0.01%	810
2021 Q2	$8.67M	Buy	1,638,400 +1,344,559	+458%	+$6.46M	0.02%	692
2021 Q1	$1.37M	Sell	293,841 -356,040	-55%	-$1.61M	﹤0.01%	1043
2020 Q4	$2.15M	Buy	649,881 +242,623	+60%	+$921K	0.01%	900
2020 Q3	$1.35M	Buy	407,258 +54,466	+15%	+$200K	0.01%	878
2020 Q2	$1.19M	Buy	352,792 +38,965	+12%	+$184K	0.01%	848
2020 Q1	$1.2M	Buy	313,827 +11,032	+4%	+$51.2K	0.01%	782
2019 Q4	$1.83M	Sell	302,795 -241,613	-44%	-$1.65M	0.01%	769
2019 Q3	$4.12M	Buy	544,408 +139,848	+35%	+$1.58M	0.03%	512
2019 Q2	$5.48M	Buy	+404,560	New	+$4.67M	0.04%	435
2018 Q1	–	Sell	-361,062	Closed	-$4.52M	–	778
2017 Q4	$4.52M	Buy	361,062 +22,510	+7%	+$258K	0.06%	195
2017 Q3	$2.83M	Buy	338,552 +35,442	+12%	+$375K	0.05%	274
2017 Q2	$5.14M	Buy	+303,110	New	+$6.03M	0.09%	149